Cell-based
kinetic studies of ligand or candidate drug binding
to membrane proteins have produced affinity and kinetic values that
are different from measurements using purified proteins. However,
ligand binding to fixated cells whose membrane constituents (e.g.,
proteins and their glycosylated forms) are partially connected by
a cross-linking reagent has not been compared to that to live cells.
Under the same experimental conditions for the LigandTracer method,
we measured the interactions of fluorophore-labeled lectins and antibody
molecules with glycans at HFF cells and the human epithelial growth
receptor 2 at SKBR3 cells, respectively. In conjunction with surface
plasmon resonance microscopy, the effects of labels and cell/sub-cell
heterogeneity on binding kinetics were investigated. Our results revealed
that, for cell constituents whose structures and functions are not
closely dependent on cell viability, the ligand binding kinetics at
fixated cells is only slightly different from that at live cells.
The altered kinetics is explained on the basis of a less mobile receptor
confined in a local environment created by partially interconnected
protein molecules. We show that cell/sub-cell heterogeneity and labels
on the ligands can alter the binding reaction more significantly.
Thus, fixating cells not only simplifies experimental procedures for
drug screening and renders assays more robust but also provides reliable
kinetic information about drug binding to cell constituents whose
structures are not changed by chemical fixation.